Could a heart pill fix depression brain fog? new trial aims to find out

NCT ID NCT06408246

Recruiting now Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 21 times

Summary

This study tests whether guanfacine, a medication currently used for blood pressure, can improve brain function and reduce depressive symptoms in people with depression. Researchers will enroll 162 adults aged 18-60 who are currently experiencing a major depressive episode. The goal is to see if the drug helps with cognitive impairments and leads to remission of depression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Stanford Psychiatry and Behavioral Sciences Department
RECRUITING

Palo Alto, California, 94305, United States
University of Illinois at Chicago
RECRUITING

Chicago, Illinois, 60607, United States

Contact

Contact

Conditions

Explore the condition pages connected to this study.

DEPRESSION